Eli Lilly stock at EUR 1,263.60, up 1.25% premarket
Published on 11/10/2026 at 07:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Matters Before The Bell
- Eli Lilly lists its Innovation Day for December 7, 2026.
- The company highlighted expanded access to FDA-approved Lilly medicines in its November 6 investor news.
- Lilly reported third-quarter results on October 29 and raised its full-year guidance.
Eli Lilly and Co. stock traded at 1,263.60 euros on Lang & Schwarz at 07:50 CET on Tuesday, November 10, 2026, 1.25 percent above the Xetra close of Monday, November 9, at EUR 1,248.00.
Pipeline And Upcoming Catalyst
Lilly's investor-relations page lists Innovation Day for December 7, 2026. The page also highlights the company's November 6 announcement on expanded access to FDA-approved Lilly medicines through an agreement with Hims & Hers. Eli Lilly investor relations also lists the October 29 third-quarter report, higher full-year guidance and regulatory progress across the portfolio.
For investors, the December event offers a scheduled point for updates on Lilly's development pipeline. The company's recent communications continue to focus on medicine access, clinical data and the outlook for its portfolio.
US market conditions can be followed through the S&P 500 market theme.
